Sarah Cannon at Menorah Medical Center is proud to be part of the Sarah Cannon HCA Midwest Health cancer network, providing local access to innovative clinical research trials, tumor profiling and genetic counseling; you can receive top cancer care in the comfort of your community hospital.
Menorah Medical Center is accredited by the American College of Surgeons' Commission on Cancer as a community hospital comprehensive cancer program with commendation for exceeding seven national standards. Sarah Cannon at Menorah Medical Center builds upon the strengths of hospital's current program including screenings, diagnosis and cancer treatments, as well as its medical-surgical inpatient oncology unit, medical oncology services, radiation therapy center, the Breast Center and some of the most advanced technology in the metro area.
Menorah Medical Center is the only facility in the greater Kansas City area to offer CyberKnife® stereotactic radiosurgery. The CyberKnife provides physicians with the ability to destroy harmful tumors without surgery or anesthesia, and with few, if any, side effects. We also offer the da Vinci® surgical robot.
Sarah Cannon at Menorah Medical Center is known for excellence in:
Screenings and Self Assessments
Menorah Medical Center strives to provide quality, evidence-based care. As an accredited Community Hospital Comprehensive Cancer Program, we use the Commission on Cancers national standards to evaluate our care of cancer patients. These are just a few examples of the quality care you can expect at Menorah Medical Center.
One of the standards of care states that palpation-guided or image-guided needle biopsy is the initial diagnosis approach rather than open biopsy. It further states that if an open biopsy is done, there should be a specific reason for the open biopsy. Menorah Medical Center diagnosed over 200 breast cancer cases in 2012. We are proud to say that we were over 99% compliant with this Commission on Cancer standard.
One of the standards of care for colon cancer looks at whether an adequate number of lymph nodes are removed and pathologically examined for certain colon cancers that are surgically removed. This means that the surgeon and pathologist work together to be sure there are enough lymph nodes examined to determine the extent of the cancer. This is important information for planning your follow-up care. When we evaluated our 2013 cases, we examined an adequate number of lymph nodes in 100% of the specified colon cancer surgeries.